GSK-LSD1 dihydrochloride
CAS No. 1431368-48-7
GSK-LSD1 dihydrochloride( —— )
Catalog No. M17295 CAS No. 1431368-48-7
GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 62 | In Stock |
|
| 10MG | 89 | In Stock |
|
| 25MG | 148 | In Stock |
|
| 50MG | 213 | In Stock |
|
| 100MG | 319 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK-LSD1 dihydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
-
DescriptionGSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorLSD1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1431368-48-7
-
Formula Weight289.24
-
Molecular FormulaC14H22Cl2N2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESc1ccc(cc1)[C@@H]1C[C@H]1NC1CCNCC1.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Structural Genomics Consortium.
molnova catalog
related products
-
EGFR Inhibitor
EGFR inhibitor is a cell permeable and selective inhibitor of EGFR kinase (IC50: 21 nM) and blocks receptor autophosphorylation in cells.
-
Cavutilide
Cavutilide has antiarrhythmic activity, inhibits hERG K(+) channels, and can be used to study heart failure and persistent atrial fibrillation.
-
Afatinib dimaleate
An irreversible, dual EGFR/HER2 inhibitor with IC50 of 0.5/0.4/10/14 nM for wt EGFR/EGFR L858R/EGFR L858R+T790M/HER2 respectively.
Cart
sales@molnova.com